PTPRD has also been shown to be involved in colon cancer cell migration via a β-catenin/TCF/CD44 signalling pathway, whereas in lung cancer, PTPRD appears to act as a tumour suppressor gene [42,43]. The gene discussed is HNF4A; the disease is malignant colon neoplasm.